MediLumine’s Mvivo Au contrast agent was injected at a dose of 0.1 ml in nude mice grafted with Sdhb(-/-) and scanned with Mediso nanoScan PET/CT at Inserm U970, Paris, France (Viel T, Yoganathan T, Perez-Liva M, Tavitian B). 3D CT images of tumor vasculature were generated with Amira 3D visualization and analysis software for life sciences (Thermo Fisher Scientific).
Highlighted Publication : New Ex Vivo Technique for Assessment of Angiogenesis
Angiogenic modulators have been closely studied as a potential therapy for peripheral artery disease and hind limb ischemia. VEGF and other angiomodulating agents have been
Jared Ledbetter
September 13, 2020
